glp-1 agonist therapy information platforms Potential Use of GLP-1 and GIP/ GLP-1 Receptor Medscape | GLP-1 receptor agonists
Description
The intricate molecular mechanisms underlying GLP-1RAs are explored, including their interactions with pathways like extracellular signal-regulated kinase 1/2 (ERK1/2), activated protein kinase (AMPK), cyclic adenine monophosphate (cAMP), mitogen-activated protein kinase (MAPK), and protein kinase C (PKC)
It is a GLP-1 agonist that can be dangerous when not used appropriately, according to a news release from the manufacturer
When the key (agonist) binds to the lock (receptor), it opens the door (activates the receptor) to produce a specific effect
Fusaroli M, Raschi E, Giunchi V, Menchetti M, Rimondini Giorgini R, De Ponti F, et al
[54] These effects are hypothesized to result from reduced maternal food intake and weight, which often accompany GLP-1 usage
Comparing these two classes of medications is important with respect to perioperative patients requiring glycemic control
